David Linetsky
2021
In 2021, David Linetsky earned a total compensation of $3.1M as SVP, Life Sciences at Phreesia.
Compensation breakdown
| Non-Equity Incentive Plan | $257,625 |
|---|---|
| Salary | $320,833 |
| Stock Awards | $2,499,896 |
| Total | $3,078,354 |
Linetsky received $2.5M in stock awards, accounting for 81% of the total pay in 2021.
Linetsky also received $257.6K in non-equity incentive plan and $320.8K in salary.
Rankings
In 2021, David Linetsky's compensation ranked 4,325th out of 12,405 executives tracked by ExecPay. In other words, Linetsky earned more than 65.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,325 out of 12,405 | 65th |
Division Services | 1,046 out of 2,289 | 54th |
Major group Business Services | 709 out of 1,535 | 54th |
Industry group Miscellaneous Business Services | 122 out of 269 | 55th |
Industry Business Services, Not Elsewhere Classified | 111 out of 236 | 53rd |
Source: SEC filing on May 25, 2021.
Linetsky's colleagues
We found four more compensation records of executives who worked with David Linetsky at Phreesia in 2021.